Ontogenetic Market to Surpass US$ 677.8 Mn by 2028

Ontogeny refers to the development of an organism while phylogeny refers to how the organisms have evolved. Ontogenetic is a developmental history of an organism, which consists of the study of social, cognitive, physical, and emotional development that can be traced to experience with the people and the environment within the environment. Ontogenetic is a huge subject and constant research in the field is expanding its applications.

Market Statistics:

The global Ontogenetic Market is estimated to account for US$ 540.3 Mn in terms of value by the end of 2022.

Drivers:

Rise in adoption of optogenetics technology is expected to boost growth of the global ontogenetic market over the forecast period. Indian Institute of Neurosciences is rapidly adopting optogenetics technology for various applications. For instance, in India, the Centre for Neuroscience, uses new techniques, such as optogenetics, along with various behavioral paradigms in mice. Moreover, the National Centre for Biological Science (NCBS) uses novel technique of optogenetics to monitor as well as to stimulate the brain cell activity using light. As the technology is still being developed, optogenetics has a wide range of potential applications that have yet to be explored. This in turn is expected to augment the growth of the global ontogenetic market.

Opportunities:

Rise in research and development (R&D) across the globe is expected to offer significant growth opportunities for players operating in the global ontogenetic market. In May 2019, the Department of Biomedical Engineering, Helwan University, Egypt, and a few other research institutes in the United Kingdom published a research study on “Wearable Glasses for Retinal Pigmentiosa Based on Optogenetics” and demonstrated that the proposed wearable device can help restore vision for Retinal Pigmentiosa patients without the need for invasive implantable device using optogenetics stimulation. Moreover, several advances in in the field of are ontogenesis are assisting research on optogenetics, driving the growth of the global ontogenetic market.

Restraints:

High cost of technology, lack of awareness, and lack of skilled personnel are some major factors expected to hamper the growth of the global ontogenetic market. Pharma companies require highly skilled professionals to develop and operate optogenetic equipment. Similarly, labor cost required for the manufacturing of final equipment is also high. Optogenetics is a new field, and it is yet to establish itself. However, with the rise in awareness among researchers about ontogenetic, the use of this technology is also increasing rapidly. This in turn is expected to increase demand for novel ontogenetic equipment across the world, driving the market growth.

Global Ontogenetic Market - Impact of Coronavirus (Covid-19) Pandemic:

Outbreak of COVID-19 had a severe impact on the ontogenetic market, as the pandemic disrupted the supply chain of pharmaceuticals, biopharmaceuticals, and medical devices around the world. However, according to the study published in July 2021 in Frontiers Media, titled “Post-Pandemic Drug Discovery and Development: Facing Present and Future Challenges”, new technologies were introduced during the pandemic, such as optogenetics. The use of such novel technologies during the pandemic is expected to boost the market growth.

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/ontogenetic-market-5474

Key Takeaways:

The global ontogenetic market was valued at US$ 522.5 Mn in 2021 and is forecast to reach a value of US$ 677.8 Mn by 2028 at a CAGR of 3.9% between 2022 and 2028.

Among application, neuroscience segment held dominant position in the global ontogenetic market in 2022, accounting for 51.2% share in terms of value, increasing approval and launch of new products is expected to propel growth of the segment during the forecast period.

Market Trends:

Increase in usage of ontogenetics as a potential diagnostic tool is one of the key trends expected to propel the growth of the biosurgery market. In addition to neurology diseases, cardiac optogenetics is an emerging research field that involves the delivery of light-sensitive proteins to enable optical modulation of cardiac electrical function. As a result, players in the market are focusing on various strategies to focus on research and development in the field of optogenetics. This trend is expected to continue over the forecast period, driving the growth of the market.

Competitive Landscape:

Major players operating in the global ontogenetic market include Bruker Corporation, Laserglow Technologies, GenSight Biologics S.A, Coherent Inc., Thorlabs Inc., Hubner group (Cobolt Inc.), Judges Scientific Plc (Scientifica), Noldus Information Technology, and Shanghai Laser & Optics Century Co. Ltd., among others.

Recent Developments:

In May 2021, Nature Medicine Journal published the first case report of partial recovery of visual function in a blind patient with late-stage retinitis pigmentosa who was a participant of PIONEER Phase I/II clinical trial of GenSight Biologics’ GS030 optogenetic therapy.

In April 2021, Laserglow Technologies acquired Readylasers to expand its diode-pumped solid-state lasers (DPSS), diode lasers, optics, related equipment and accessories portfolio, and to expend DPSS laser systems application in Optogenetics.

In April 2019, HUBNER photonics expanded its presence in North America with the expansion of Cobolt Inc. and opening a new office in the United States.